3SBio (1530.HK) Priced

Leading Chinese biotech with drugs for anemia and low blood platelets.

Health Care - Biotechnology

IPO Performance
Latest Trade $7.80 0.00 (0.0%)
First Day Return 699.1%
Return from IPO 566.7%
 
3SBio IPO News more
  • .
IPO Data
IPO File Date 02/17/2015
Offer Price $1.17
Price Range $1.07 - $1.17
Offer Shares (mm) 606.1
Deal Size ($mm) 709
 
IPO Data
IPO Date 06/04/2015
Offer Price $1.17
Price Range $1.07 - $1.17
Offer Shares (mm) 606.1
Deal Size ($mm) $709
 
Underwriters
more
Business Overview
Leading Chinese biotech with drugs for anemia and low blood platelets.
Leading Chinese biotech with drugs for anemia and low blood platelets.
more
Company Data
Headquarters Shenyang, , China
Founded 1993
Employees n/a
Website www.3sbio.com
 

Performance vs. IPO Index (IPOUSA)